A study to compare the safety and efficacy of Amitriptyline and Gabapentin in Herpes zoster associated pain.
Phase 4
- Conditions
- Health Condition 1: null- Zoster associated pain
- Registration Number
- CTRI/2015/09/006159
- Lead Sponsor
- Medical College Kolkata
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 82
Inclusion Criteria
i.The patients presenting with active herpes zoster lesions with associated ZAP.
ii.Patients who give their informed consent.
iii.Age group: 18 years to 80 years
Exclusion Criteria
i.Patients not giving their informed consent.
ii.Pregnant or lactating women
iii.Patients who have participated in a clinical trial in the past 3 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method McGill pain questionnaire (MPQ)Timepoint: baseline, 1 week, 4 weeks, 12 weeks
- Secondary Outcome Measures
Name Time Method Dermatologic Life Quality Index: Vernacular validated version usedTimepoint: baseline, 1 week, 4 weeks, 12 weeks;Patients Global Assesment (PGA) Scale: Score of 0-10 (10- maximum pain; 0- No pain) <br/ ><br>Timepoint: baseline, 1 week, 4 weeks, 12 weeks